Literature DB >> 22234172

Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis.

Wei Zhong1, Yantao Zhao2, Yunan Tang3, Xiaoli Wei4, Xue Shi4, Wenlong Sun4, Xiuhua Sun1, Xinmin Yin4, Xinguo Sun1, Seongho Kim5, Craig J McClain6, Xiang Zhang7, Zhanxiang Zhou8.   

Abstract

Alcohol consumption induces liver steatosis; therefore, this study investigated the possible role of adipose tissue dysfunction in the pathogenesis of alcoholic steatosis. Mice were pair-fed an alcohol or control liquid diet for 8 weeks to evaluate the alcohol effects on lipid metabolism at the adipose tissue-liver axis. Chronic alcohol exposure reduced adipose tissue mass and adipocyte size. Fatty acid release from adipose tissue explants was significantly increased in alcohol-fed mice in association with the activation of adipose triglyceride lipase and hormone-sensitive lipase. Alcohol exposure induced insulin intolerance and inactivated adipose protein phosphatase 1 in association with the up-regulation of phosphatase and tensin homolog (PTEN) and suppressor of cytokine signaling 3 (SOCS3). Alcohol exposure up-regulated fatty acid transport proteins and caused lipid accumulation in the liver. To define the mechanistic link between adipose triglyceride loss and hepatic triglyceride gain, mice were first administered heavy water for 5 weeks to label adipose triglycerides with deuterium, and then pair-fed alcohol or control diet for 2 weeks. Deposition of deuterium-labeled adipose triglycerides in the liver was analyzed using Fourier transform ion cyclotron mass spectrometry. Alcohol exposure increased more than a dozen deuterium-labeled triglyceride molecules in the liver by up to 6.3-fold. These data demonstrate for the first time that adipose triglycerides due to alcohol-induced hyperlipolysis are reverse transported and deposited in the liver. Copyright Â
© 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234172      PMCID: PMC3349880          DOI: 10.1016/j.ajpath.2011.11.017

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Influence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition?

Authors:  G Addolorato; E Capristo; A V Greco; G F Stefanini; G Gasbarrini
Journal:  J Intern Med       Date:  1998-11       Impact factor: 8.989

2.  Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: new findings from metabolic assessment.

Authors:  G Addolorato; E Capristo; A V Greco; G F Stefanini; G Gasbarrini
Journal:  Alcohol Clin Exp Res       Date:  1997-09       Impact factor: 3.455

Review 3.  Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.

Authors:  David W Crabb; Andrea Galli; Monika Fischer; Min You
Journal:  Alcohol       Date:  2004-08       Impact factor: 2.405

Review 4.  The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes.

Authors:  Kenneth Cusi
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

Review 5.  Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.

Authors:  Min You; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07       Impact factor: 4.052

Review 6.  Adiponectin: a key adipokine in alcoholic fatty liver.

Authors:  Min You; Christopher Q Rogers
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

7.  Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.

Authors:  May-Yun Wang; Paul Grayburn; Shuyuan Chen; Mariella Ravazzola; Lelio Orci; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

Review 8.  Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly.

Authors:  M Mahmood Hussain; Jason Shi; Paul Dreizen
Journal:  J Lipid Res       Date:  2003-01       Impact factor: 5.922

9.  Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.

Authors:  M Tahara; K Matsumoto; T Nukiwa; T Nakamura
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation.

Authors:  Li Kang; Xiaocong Chen; Becky M Sebastian; Brian T Pratt; Ilya R Bederman; James C Alexander; Stephen F Previs; Laura E Nagy
Journal:  J Biol Chem       Date:  2007-08-07       Impact factor: 5.157

View more
  96 in total

Review 1.  Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease.

Authors:  Sathish Kumar Natarajan; Karuna Rasineni; Murali Ganesan; Dan Feng; Benita L McVicker; Mark A McNiven; Natalia A Osna; Justin L Mott; Carol A Casey; Kusum K Kharbanda
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.

Authors:  Zhigang Wang; Xiaobing Dou; Songtao Li; Ximei Zhang; Xinguo Sun; Zhanxiang Zhou; Zhenyuan Song
Journal:  Hepatology       Date:  2014-02-25       Impact factor: 17.425

3.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

4.  Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice.

Authors:  Hong Shen; Lin Jiang; Jiandie D Lin; M Bishr Omary; Liangyou Rui
Journal:  J Clin Invest       Date:  2019-03-19       Impact factor: 14.808

5.  Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.

Authors:  Thiyagarajan Gopal; Narendra Kumar; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Edward N Harris; Geoffrey Talmon; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

6.  CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis.

Authors:  Robin D Clugston; Jason J Yuen; Yunying Hu; Nada A Abumrad; Paul D Berk; Ira J Goldberg; William S Blaner; Li-Shin Huang
Journal:  J Lipid Res       Date:  2013-11-26       Impact factor: 5.922

7.  Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Yongliang Xia; Jing Chen; Ying Qian; Songtao Li; Ximei Zhang; Zhenyuan Song
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

8.  Chronic alcohol exposure alters circulating insulin and ghrelin levels: role of ghrelin in hepatic steatosis.

Authors:  Karuna Rasineni; Paul G Thomes; Jacy L Kubik; Edward N Harris; Kusum K Kharbanda; Carol A Casey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-01-31       Impact factor: 4.052

9.  Leptin deficiency contributes to the pathogenesis of alcoholic fatty liver disease in mice.

Authors:  Xiaobing Tan; Xiuhua Sun; Qiong Li; Yantao Zhao; Wei Zhong; Xinguo Sun; Wei Jia; Craig J McClain; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

10.  Decreased Whole-Body Fat Mass Produced by Chronic Alcohol Consumption is Associated with Activation of S6K1-Mediated Protein Synthesis and Increased Autophagy in Epididymal White Adipose Tissue.

Authors:  Kristen T Crowell; Jennifer L Steiner; Catherine S Coleman; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2016-07-27       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.